In the field of neurology, loss of PKR increases the late phase of long-lasting synaptic potentiation in hippocampal slices and neurodegeneration in Alzheimer’s disease, and PKR inhibitor treatment rescues these unfavorable states18,19. This evidence concerns the gene EIF2AK2 and early-onset autosomal dominant Alzheimer disease.